How AI can accelerate the search for treatments for emerging and intractable diseases
Artificial intelligence (AI) models and algorithms can save time and money in the search for drug candidates for emerging diseases, including COVID-19.
Joanna is CEO of BenevolentAI, the world leader in the development and application of AI and machine learning to accelerate drug discovery and develop new medicines for hard to treat diseases.
Before joining Benevolent AI, Joanna served as the UK’s first Minister for Internet Safety and Security, a Special Advisor to the UK Government on the Digital Economy, and Chair & CEO of TechCityUK. During this time, she also founded WePROTECT, a global alliance to protect children from online abuse and exploitation.
Joanna started her career in Silicon Valley and spent 25 years in leadership positions at companies such as Facebook, Bebo/Aol, Google, and EFI. She also served as a non-executive director of the London Stock Exchange Group, TalkTalk and MindCandy.